Amanda K. Nosie

741 total citations
5 papers, 603 citations indexed

About

Amanda K. Nosie is a scholar working on Ophthalmology, Immunology and Allergy and Cancer Research. According to data from OpenAlex, Amanda K. Nosie has authored 5 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Ophthalmology, 2 papers in Immunology and Allergy and 2 papers in Cancer Research. Recurrent topics in Amanda K. Nosie's work include Cell Adhesion Molecules Research (2 papers), Glaucoma and retinal disorders (2 papers) and Protease and Inhibitor Mechanisms (2 papers). Amanda K. Nosie is often cited by papers focused on Cell Adhesion Molecules Research (2 papers), Glaucoma and retinal disorders (2 papers) and Protease and Inhibitor Mechanisms (2 papers). Amanda K. Nosie collaborates with scholars based in United States and Australia. Amanda K. Nosie's co-authors include Thomas P. Burris, Pengxiang Huang, Keith R. Stayrook, Pamela M. Rogers, Sepideh Khorasanizadeh, Fraydoon Rastinejad, Don B. McClure, Srilatha Raghuram, Donna M. Peters and Mark S. Filla and has published in prestigious journals such as European Heart Journal, Nature Structural & Molecular Biology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Amanda K. Nosie

4 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amanda K. Nosie United States 3 262 204 126 108 100 5 603
Min Han China 13 739 2.8× 85 0.4× 71 0.6× 34 0.3× 58 0.6× 15 904
Rehwa H. Lee United States 14 699 2.7× 103 0.5× 45 0.4× 98 0.9× 69 0.7× 17 814
Małgorzata Piechota Poland 12 701 2.7× 27 0.1× 208 1.7× 111 1.0× 56 0.6× 16 923
Kenneth P. Mitton United States 18 727 2.8× 29 0.1× 113 0.9× 327 3.0× 178 1.8× 47 1.1k
I Tsukahara Japan 16 407 1.6× 35 0.2× 99 0.8× 167 1.5× 139 1.4× 56 632
B. Omri France 14 318 1.2× 30 0.1× 51 0.4× 219 2.0× 55 0.6× 27 661
Linda Barsalou United States 10 506 1.9× 97 0.5× 31 0.2× 197 1.8× 34 0.3× 15 599
Dennis M. Maddox United States 12 404 1.5× 24 0.1× 57 0.5× 52 0.5× 71 0.7× 15 625
Richard B. Crook United States 16 398 1.5× 20 0.1× 85 0.7× 97 0.9× 44 0.4× 28 599
C.L. Kapoor United States 13 336 1.3× 45 0.2× 57 0.5× 26 0.2× 53 0.5× 25 483

Countries citing papers authored by Amanda K. Nosie

Since Specialization
Citations

This map shows the geographic impact of Amanda K. Nosie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda K. Nosie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda K. Nosie more than expected).

Fields of papers citing papers by Amanda K. Nosie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda K. Nosie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda K. Nosie. The network helps show where Amanda K. Nosie may publish in the future.

Co-authorship network of co-authors of Amanda K. Nosie

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda K. Nosie. A scholar is included among the top collaborators of Amanda K. Nosie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda K. Nosie. Amanda K. Nosie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Perez, Carlos A., G Sánz, Julián Priego, et al.. (2023). Discovery and preclinical development of LY3473329, a potent small molecule inhibitor of lipoprotein(a) formation. European Heart Journal. 44(Supplement_2).
2.
Nosie, Amanda K., Teresa M. Walker, Jennifer A. Faralli, et al.. (2012). Comparative Genomic and Proteomic Analysis of Cytoskeletal Changes in Dexamethasone-Treated Trabecular Meshwork Cells. Molecular & Cellular Proteomics. 12(1). 194–206. 63 indexed citations
3.
Filla, Mark S., et al.. (2011). β3 Integrin Signaling Is Involved In Dexamethasone-induced Cross-linked Actin Network (CLAN) Formation In Human Trabecular Meshwork (HTM) Cells. Investigative Ophthalmology & Visual Science. 52(14). 4656–4656. 1 indexed citations
4.
Filla, Mark S., et al.. (2011). Dexamethasone-Associated Cross-Linked Actin Network Formation in Human Trabecular Meshwork Cells Involves β3 Integrin Signaling. Investigative Ophthalmology & Visual Science. 52(6). 2952–2952. 76 indexed citations
5.
Raghuram, Srilatha, Keith R. Stayrook, Pengxiang Huang, et al.. (2007). Identification of heme as the ligand for the orphan nuclear receptors REV-ERBα and REV-ERBβ. Nature Structural & Molecular Biology. 14(12). 1207–1213. 463 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026